Transcript: Olga Stefanishyna, Ukrainian Ambassador to the U.S., on "Face the Nation with Margaret Brennan," Nov. 23, 2025

U.S.-backed consultations in Geneva continue over a U.S. “28-point” peace proposal and a separate U.S. security-assurances framework as Ukraine negotiates under mounting battlefield pressure, notably around Pokrovsk. The leaked framework signals U.S. intent to provide assurance akin to Article 5 but stops short of a treaty or explicit commitment to direct military intervention, while Kyiv seeks clear, written guarantees; reports that Washington may condition continued military/intelligence support on timely acceptance of terms add near-term geopolitical and risk-premium uncertainty for markets.

Analysis

Market structure shifts toward defense primes and safe-haven assets: shorter-term risk premia favor prime U.S. contractors (LMT, NOC, RTX) and sovereign debt while cyclicals and EM carry are pressured; pricing power for primes improves as conditional U.S. assurance increases probability of sustained procurement over 12–36 months. Supply/demand for materiel tilts tighter — expect order-visibility improvements for missile, ISR, and munitions suppliers, but uneven upstream bottlenecks (semiconductors, specialty metals) could cap immediate margin gains.

Tail-risk spectrum is skewed: low-probability escalation could push Brent >$110/barrel and DXY >2–3% in a week, while a rapid diplomatic settlement would reverse risk premia and compress defense equity volatility. Immediate (days) moves will be driven by headlines and market positioning; 1–3 month effects hinge on Congressional and Kyiv decisions; 6–24 month outcomes depend on formalized aid pipelines and procurement commitments. Hidden dependency: continued U.S. support may be conditioned on Kyiv procurement preferences, favoring U.S. suppliers and creating durable revenue streams for select primes.

Trading implications: expect elevated IV in defense and commodity names — use short-dated call spreads to capture event-driven moves and LEAPS to express structural rearmament. Cross-asset: bid for TLT and GLD on headline shock; USD and core yields likely to rally on risk-off, widening EM sovereign spreads by 50–150bp. Watch order flow into defense ETFs and 3–6 month skew as a barometer of sustained repositioning.

Contrarian view: the market underprices persistent defense capex — post-2014/2022 patterns show multi-year contract rollouts and backlog conversion that can lift EPS 10–20% above consensus over 12–24 months. Conversely, a negotiated settlement would snap risk premia and penalize overlevered cyclical longs; the optimal stance is asymmetric — long durable defense optionality while hedging macro beta.

Key Decisions for Investors

• Establish a 1.5–2.0% portfolio position in U.S. prime defense via equal-weight LMT, NOC, RTX exposure: split 50% via Jan 2026 LEAPS (≈10% OTM) and 50% via 3-month 5% OTM call spreads to capture both structural upside and near-term headline-driven re-ratings; trim if shares +20% or backlog announcements increase by >15% QoQ.
• Allocate 1.0–1.5% to GLD as a volatility hedge (buy GLD and pair with 1-month ATM calls if VIX >22); liquidate or reduce by half if DXY falls below 101 or GLD gains >8% from entry within 60 days.
• Deploy a 2.0–3.0% defensive duration hedge: buy TLT if 10-year U.S. yield drops below 3.6% (target entry band 3.0–3.6%); position to capture a 3–7% price rally in a risk-off episode, exit when yields rebound above 4.0% or equity VIX normalizes <18.
• Execute a relative-value pair for 1–3 months: long LMT (size per above) and short IWM equal notional (net small negative beta) to express defense outperformance versus small-cap cyclicals during headline-driven risk-off; unwind if Geneva accords accepted within 30–60 days or if LMT underperforms IWM by >8%.